Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience.

ABSTRACT:

Purpose

To characterize our experience and the disease control and toxicity of proton therapy (PT) for patients with head and neck cancer (HNC).

Patients and methods

Clinical outcomes for patients with HNC treated with PT at our institution were prospectively collected in 2 institutional review board-approved prospective studies. Descriptive statistics were used to summarize patient characteristics and outcomes. Overall survival, local-regional control, and disease-free survival were estimated by the Kaplan-Meier method. Treatment-related toxicities were recorded according to the Common Terminology Criteria for Adverse Events (version 4.03) scale.

Results

The cohort consisted of 573 patients treated from February 2006 to June 2018. Median patient age was 61 years. Oro

SUBMITTER: Gunn GB 

PROVIDER: S-EPMC8270083 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature